Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mukka ProteinsNSE:MUKKA -1.13%35 EBITDA per Share is ₹4.86 as of Mar. 2026. GuruFocus rates NSE:MUKKA with a GF Score™ of 35/100. The stock has 8 warning signs investors should review. Among 1,664 Consumer Packaged Goods companies, Mukka Proteins ranks better than 66.59% on this metric.
Mukka Proteins's EBITDA per Share for the
three
months ended in Mar. 2026 was ₹1.65.
Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.86.
During the past 12 months, the average EBITDA per Share Growth Rate of Mukka Proteins was 31.10% per year.
During the past 3 years, the average EBITDA per Share Growth Rate was 17.70% per year.
During the past 5 years, the average EBITDA per Share Growth Rate was 35.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.
The historical rank and industry rank for Mukka Proteins's EBITDA per Share or its related term are showing as below:
NSE:MUKKA'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 17.7 Med: 28.7 Max: 71.8
Current: 17.7
During the past 8 years, the highest 3-Year average EBITDA per Share Growth Rate of Mukka Proteins was 71.80% per year. The lowest was 17.70% per year. And the median was 28.70% per year.
NSE:MUKKA's 3-Year EBITDA Growth Rate is ranked better than 66.59% of 1664
companies
in the Consumer Packaged Goods industry
Industry Median: 7.9
vs NSE:MUKKA: 17.70
During the past 12 months, the average EBITDA Growth Rate of Mukka Proteins was 30.90% per year.
During the past 3 years, the average EBITDA Growth Rate was 17.60% per year.
During the past 5 years, the average EBITDA Growth Rate was 34.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.
During the past 8 years, the highest 3-Year average EBITDA Growth Rate of Mukka Proteins was 56.30% per year. The lowest was 17.60% per year. And the median was 28.70% per year.
Mukka Proteins (NSE:MUKKA) EBITDA per Share Explanation
EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.
While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.
The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.
EBITDA can be thought of as the cash a business generates that is available to:
Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners
EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.
A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.
Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.
Be Aware
Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.
EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.
Mukka Proteins EBITDA per Share Related Terms
Mukka Proteins EBITDA per Share Historical Data
* Premium members only.
The historical data trend for Mukka Proteins's EBITDA per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Mukka Proteins's EBITDA per Share for the fiscal year that ended in Mar. 2026 is calculated as
EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.86
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukka Proteins (NSE:MUKKA) has a EBITDA per Share of ₹4.86 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Mukka Proteins and its competitors. According to the industry distribution chart, Mukka Proteins ranks #556 out of 1664 companies in the Consumer Packaged Goods industry, placing it in the top 33.4%.
Is Mukka Proteins' EBITDA per Share too high?
Mukka Proteins' current EBITDA per Share is ₹4.86. Based on the distribution chart, Mukka Proteins ranks #556 out of 1664 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Mukka Proteins has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Mukka Proteins' EBITDA per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Mukka Proteins ranks #556 out of 1664 companies for EBITDA per Share. This puts Mukka Proteins in the upper half of its industry. The industry median EBITDA per Share is 7.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Consumer Packaged Goods company?
The median EBITDA per Share among Consumer Packaged Goods companies is 7.90, based on 1,664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Mukka Proteins and its competitors. For the Consumer Packaged Goods industry, the median EBITDA per Share is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mukka Proteins's current EBITDA per Share is ₹4.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mukka Proteins stock overvalued right now?
Mukka Proteins (NSE:MUKKA) has a current EBITDA per Share of ₹4.86. The current EBITDA per Share is ₹4.86. Mukka Proteins' overall GF Score™ is 35/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Mukka Proteins (NSE:MUKKA), the current EBITDA per Share is ₹4.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mukka Proteins Ltd is an animal protein company. The company manufactures and supplies fish meal, fish oil, and fish soluble paste, which is an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broilers and layers), and pet food. Fish oil of the company also finds its application in pharmaceutical products (additionally, Omega-3 pills and related products derived from fish oil are gaining importance as high-nutrient and healthy dietary supplements), soap manufacturing, leather tanneries & paint industries. The company sells its products domestically and also exports them to over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam.
35GF Score
Get the complete analysis for NSE:MUKKA
EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MUKKA has been successfully added to your 
